Screener
Artiva Biotherapeutics, Inc. ARTV Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent.
The source filing: Artiva Biotherapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338029
FAQ
- What is Artiva Biotherapeutics, Inc.'s operating lease ROU assets?
- Artiva Biotherapeutics, Inc. (ARTV) reported operating lease ROU assets of 8% in Q2 2026.
- How has Artiva Biotherapeutics, Inc.'s operating lease ROU assets changed year-over-year?
- Artiva Biotherapeutics, Inc.'s operating lease ROU assets increased by 3.9% year-over-year, from 7.7% to 8%.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s operating lease ROU assets?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s operating lease ROU assets has grown at a -100.0% compound annual growth rate (CAGR), from 1,654,700,000% to 8%.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Artiva Biotherapeutics, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude